NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/18/2025
Back to search
Official data from USPTO
HEMERION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HEMERION
ST13
US500000090554690Class
5, 10, 42
Filing
90554690
Registration
7697787
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
02/18/2025
Trademark type
Word
Nice classes
5, 10, 42
Filing date
03/02/2021
Registration date
02/18/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2025
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/01/2023
First use in commerce
04/11/2024
Drawing code
4
Owner type
99
Owner location
Villeneuve-d'Ascq, FR
Examiner
PILARO, MARK F
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
H. T. (pessoa física)
Representatives
Pina Campagna CARTER, DELUCA AND FARRELL LLP
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the prevention and treatment of cancer; pharmaceuticalmedical and veterinary preparations for the prevention and treatment of cancer; Sanitary preparations for medical purposes; Pharmaceutical preparations for the diagnosis and treatment of oncological and inflammatory diseases and disorders; Medicinal preparations for the treatment of infectious diseases and for use in oncology
Class 10
(Based on 44(e)) Surgical and medical apparatus and instrumentssurgical instruments and apparatusmedical devices for detecting and treating cancerx-ray apparatus and surgical apparatus and instruments for medical use; Medical imaging apparatus; Medical instruments for diagnosis and treatment of cancer; Lasers for surgical and medical use; Medical apparatus for the treatment of cancerous tumors; Radiological apparatus for medical purposes; Medical imaging apparatus for use in the field of oncology for diagnostic purposes; Radiotherapy apparatus; Medical diagnostic apparatus for detecting or testing cancer; Implantable subcutaneous drug delivery apparatusspecificallyimplantable drug delivery ports and implantable drug delivery pumps; fluid injectors for medical purposes; probes for medical purposes
Class 42
(Based on 44(e)) Scientific research for medical and surgical purposes in the field of cancerous diseases; Pharmaceutical research and development; Scientific and medical research in the field of lasers; Scientific research for medical and surgical purposes in the field of oncologyspecificallycancerous diseases; Conducting clinical trials as pharmaceutical research for others in the pharmaceutical field; Conduction preclinical trials as pharmaceutical research for others in the pharmaceutical field; in-vitro testing servicesspecificallyin vitro pharmaceutical testing being pharmaceutical research in the pharmaceutical field; scientific studies and research for medical and surgical purposes in the field of oncologyspecificallycancerous diseases; medicalpharmacologicalbiological and chemical studies and research all being scientific research for surgical and medical purposes in the field of cancerous diseases; pharmaceutical research and development of new medical devices and pharmaceutical products; pharmaceutical research servicesperformance of biologicalchemical and pharmacological analyses of pharmaceutical products
Publications
History of USPTO decisions and trademark events.
42 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/28/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/28/2025
DOCK
ASSIGNED TO EXAMINER
01/13/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/11/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/11/2024
IUAF
USE AMENDMENT FILED
07/10/2024
EISU
TEAS STATEMENT OF USE RECEIVED
07/10/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/23/2024
EX4G
SOU EXTENSION 4 GRANTED
01/19/2024
EXT4
SOU EXTENSION 4 FILED
01/19/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/19/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/22/2023
EX3G
SOU EXTENSION 3 GRANTED
07/20/2023
EXT3
SOU EXTENSION 3 FILED
07/20/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/13/2023
EX2G
SOU EXTENSION 2 GRANTED
01/11/2023
EXT2
SOU EXTENSION 2 FILED
01/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/29/2022
EX1G
SOU EXTENSION 1 GRANTED
06/27/2022
EXT1
SOU EXTENSION 1 FILED
06/27/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/27/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/25/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/30/2021
PUBO
PUBLISHED FOR OPPOSITION
11/30/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/10/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
10/28/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
10/22/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/21/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/21/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/21/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/21/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/21/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/28/2021
GNRT
NON-FINAL ACTION E-MAILED
09/28/2021
CNRT
NON-FINAL ACTION WRITTEN
09/28/2021
DOCK
ASSIGNED TO EXAMINER
09/22/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2021
NWAP
NEW APPLICATION ENTERED
03/05/2021
Continuous trademark protection
Get notified about every new filing that threatens HEMERION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.